Psoriasis drug shows promise in type 1 diabetes treatment: Study
Psoriasis drug shows promise in type 1 diabetes treatment, according to a study. Psoriasis and type 1 diabetes are autoimmune disorders, and the drug alefacept works to suppress the immune system, which is often overactive in immune disorders. Alefacept was pulled in 2001 due to “business needs,” so it is no longer used to treat ...click here to read more
